公司概覽
業務類別 Biotechnology
業務概覽 Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
公司地址 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
電話號碼 +44 2074003347
傳真號碼 --
公司網頁 https://www.roivant.com
員工數量 721
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Frank M. Torti, M.D. Co-President 美元 725.00K 29/07/2026
Dr. Eric Venker, M.D.,Pharm.D. Co-President; Chief Executive Officer, Immunovant 美元 75.00K 29/07/2026
Mr. Matthew Gline Chief Executive Officer and Director 美元 725.00K 29/07/2026
Dr. Mayukh Sukhatme Co-President, Chief Investment Officer and Director 美元 550.00K 29/07/2026
Mr. Richard Pulik Chief Financial Officer 美元 450.88K 29/07/2026
Ms. Jennifer Humes Chief Accounting Officer; Chief Accounting Officer of Roivant Sciences, Inc. -- 29/07/2026
 
董事會成員
董事會 職務 更新日期
Mr. James C. Momtazee Independent Director 29/07/2026
Dr. Meghan M. Fitzgerald, Ph. Independent Director 29/07/2026
Mr. Keith Manchester, M.D. Independent Director 29/07/2026
Mr. Ilan Oren Chairman of the Board 29/07/2026
Ms. Melissa B. Epperly Independent Director 29/07/2026
Mr. Daniel Gold Independent Director 29/07/2026
Mr. Matthew Gline Chief Executive Officer and Director 29/07/2026
Dr. Mayukh Sukhatme Co-President, Chief Investment Officer and Director 29/07/2026
 
所屬ETF (更新日期: 11/11/2026 03:45)
代號 名稱 佔比% ▼ 持有日期
CVMCCalvert US Mid-Cp Cor Rspnb ETF0.001%30/10/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.001%30/10/2026
BMEDiShares Health Innovation Active ETF0.001%30/10/2026
REVSColumbia Research Enhanced Value ETF0.001%31/10/2026
KOKUXtrackers MSCI Kokusai Equity ETF0.001%29/10/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%30/10/2026
HELXFranklin Genomic Advancements ETF0.001%31/10/2026
TDNAT. Rowe Price Biotech ETF0.0004%31/10/2026
TECHarbor Transformative Technologies ETF0.0004%31/10/2026
SMDXIntech S&P Small-Mid Cap Divers Alp ETF0.0004%30/10/2026
UMDDProShares UltraPro MidCap4000.0004%30/10/2026
MFUSPIMCO RAFI Dyn Multi-Factor US Eq ETF0.0004%30/10/2026
XMAGDefiance Large Cap ex-Mag 7 ETF0.0003%30/10/2026
PJSMPGIM Jennison Small-Mid Cap Core Eq ETF0.0003%30/10/2026
WDNAWisdomTree BioRevolution ETF0.0003%30/10/2026
TMEDT. Rowe Price Health Care ETF0.0003%31/10/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0003%30/10/2026
TNXTT. Rowe Price Innovation Leaders ETF0.0002%31/10/2026
STXVStrive 1000 Value ETF0.0002%30/10/2026
AVTMAvantis Total Equity Markets ETF0.0002%30/10/2026
  1    2    3    4    5    6   7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.